Literature DB >> 29067786

Long-term safety of different antihypertensive regimens: The risk of unfair comparisons.

Costas Thomopoulos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29067786      PMCID： PMC8030776          DOI： 10.1111/jch.13125

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  4 in total

Review 1.  Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.

Authors:  Barry L Carter; Michael E Ernst; Jerome D Cohen
Journal:  Hypertension       Date:  2003-11-24       Impact factor: 10.190

2.  Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes.

Authors:  Yoichiro Hirakawa; Hisatomi Arima; Ruth Webster; Sophia Zoungas; Qiang Li; Stephen Harrap; Liu Lisheng; Pavel Hamet; Giuseppe Mancia; Neil Poulter; Bruce Neal; Bryan Williams; Anthony Rogers; Mark Woodward; John Chalmers
Journal:  J Hypertens       Date:  2016-04       Impact factor: 4.844

Review 3.  Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events - meta-analyses of randomized trials.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2016-08       Impact factor: 4.844

4.  Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide.

Authors:  Joel M Neutel; William C Cushman; Eric Lloyd; Bruce Barger; Alison Handley
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-06       Impact factor: 3.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.